Search results
AstraZeneca cops to rare, deadly side effect of COVID jab as lawsuits mount
New York Post· 2 days agoAstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting...
The two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 14 hours agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 vaccine so violent that hospital doctors ...
AP source: J&J doses to be released, but many will be tossed
AOL· 10 hours agoU.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19 ...
Coroner issues warning after man, 28, given fatal Covid jab because of GP data blunder
Daily Telegraph· 20 hours agoOn March 21 2021, Mr Reid was given his first dose of the Oxford AstraZeneca vaccine. Mr Longstaff...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 6 days agoA major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the...
Uveitis History Linked to Recurrence After COVID Vaccination
MedPage Today· 6 days ago(HR 2.07, 95% CI 1.40-3.07). "These findings suggest that there was an elevated risk of uveitis...
Pandemic treaty will give WHO power to demand 20pc of British vaccines
Daily Telegraph· 3 days agoBritain was among the first countries to develop and roll out a Covid vaccine, the AstraZeneca jab,...
Q&A: Scientist who helped design R21 anti-malaria vaccine reflects on 30 years of research, and what...
Medical Xpress· 6 days agoAdrian Hill, director of the Jenner Institute at the University of Oxford and chief investigator for...
Closed for business: The 11 moments that defined the European Parliament's term
Euronews via Yahoo News· 6 days agoPharma CEOs face the music AstraZeneca CEO Pascal Soriot faced the fury of MEPs over repeated delays...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 21 hours agoThe Phase 1 clinical trial, protocol number KM-NVCoV2-001, which received approval from the...